News and Announcements
PEF Capital Market Wrap 9th of July 2018
- Published July 09, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Qantas Airways (ASX:QAN) faces increasing costs
- Wesfarmers: key drivers behind the business in CY2017
- Wesfarmers exit from metallurgical coal well timed
- Chinese’s slowing economy has a large impact on Australian companies
Join PEF Capital in this weeks (9th of July) Market Wrap. Providing Wholesale Investor users with an overview of how the PEF Capital considers various companies it trades.
We saw last week finish with $34 billion of tariffs on US imports against China taking effect. The Australian market finished at 10.5 year high with the S&P/ASX 200 (ASX:XJO) index rising another 1.2 percent.
View PEF Capitals entire 9th of July Market Wrap
About PEF Capital:
PEF Capital is a specialist fund manager that operates an absolute return fund focussed on achieving 36% to 48% per annum (before fees). The fund is beta-uncorrelated and can act as a primary investment focus or be used hedge a full-complement portfolio for wholesale investors.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
